Fusidic acid, tetracycline, virginiamycin |
Diverse |
High toxicities at clinically applied doses |
[72] |
Gentamycin |
Diverse |
Favorable safety profile at low concentrations |
[73, 83] |
Impaired cell migration and proliferation at higher concentrations (0.1 to 1.0 mg/mL), thus the clinically applied dose in topical preparations (about 0.1% or 1 mg/g) may impair cell function |
Mafenide |
Sulfamylon® |
Cytotoxic even at lower local concentrations, therefore not suitable as a topical agent |
[83] |
Phenoxyethanol |
Diverse |
Promising alternative to antiseptic solutions |
[72] |
Polymyxin B |
Diverse |
Dose-dependent detrimental effects |
[83] |
Polymyxin B sulfate in combination with bacitracin |
Polysporin® |
Impaired proliferation at higher concentrations with the main effect being mediated by polymyxin B sulfate |
[83] |
Polymyxin B sulfate in combination with neomycin sulfate |
Neosporin® |
Much more favorable safety profile, containing far less polymyxin B but exerting excellent antimicrobiotic effects, discussed as a well-suited topical antibiotic |
[83] |
Povidone-iodine |
Diverse |
Toxicity depends on the presence of serum (higher without) |
[72] |